Solid Biosciences LLC (SLDB) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $6.29
• Market Cap: $491.61M
• EPS: $-2.48
• 52-Week High: $7.37
• 52-Week Low: $2.41

Market Sentiment

Solid Biosciences LLC currently has a Neutral sentiment score of -0.04.

About Solid Biosciences LLC

Solid Biosciences Inc. is a leading life sciences company dedicated to developing innovative gene therapies for Duchenne muscular dystrophy (DMD), a debilitating genetic disorder predominantly impacting young boys. Based in Cambridge, Massachusetts, the company is focused on addressing significant unmet medical needs through its advanced pipeline aimed at restoring functional dystrophin. By prioritizing translational science and leveraging collaborations within the DMD community, Solid Biosci...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Solid Biosciences LLC and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does SLDB pay dividends?

Solid Biosciences LLC (SLDB) does not currently pay a regular dividend.

What is SLDB's market cap?

Solid Biosciences LLC (SLDB) has a market capitalization of $491.61M with a current stock price of $6.29.